Repare Therapeutics Raises US$68 M Series A
July 05, 2017
Novel cancer company founded by Versant Ventures
Repare Therapeutics Inc. today announced a US$68 million Series A financing to advance its platform and pipeline of novel medicines that target genetically defined weaknesses of cancers.
Click here to view the press release.